The following is a summary of “Patient preferences for treatment of Bowen’s disease,” published in the December 2024 issue of ...

Once daily, 1 week AK lesion reduction from baseline: 28.8 Complete clearance: 0 AK lesion reduction from baseline: 62.6 Complete clearance: 18.1 <0.001 <0.001 In 5-FU group application, site ...

But with significant side effects, accessibility and cost issues ... we're taking holistic approach to treatment to address all," Dr. Joyce says. "Our InuMCT microcapsules deliver a viable ...